Keay Nakae
Stock Analyst at Chardan Capital
(3.53)
# 857
Out of 4,944 analysts
246
Total ratings
35.71%
Success rate
9.02%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $2.66 | +651.88% | 12 | Aug 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $18.93 | +32.07% | 3 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $6.20 | +125.81% | 20 | Aug 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $19.99 | +200.15% | 20 | Aug 11, 2025 | |
| ABUS Arbutus Biopharma | Maintains: Buy | $5 | $3.37 | +48.37% | 13 | Aug 11, 2025 | |
| PRQR ProQR Therapeutics | Maintains: Buy | $4 | $2.02 | +98.51% | 15 | Aug 8, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $75 | $46.15 | +62.51% | 18 | Aug 8, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $20 → $12 | $2.16 | +455.56% | 16 | Aug 8, 2025 | |
| SLN Silence Therapeutics | Maintains: Buy | $35 | $5.82 | +501.37% | 13 | Aug 8, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $325 → $400 | $432.52 | -7.52% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $38 | $12.24 | +210.46% | 13 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $0.73 | +585.87% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $32.91 | +82.32% | 1 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $15.97 | -62.43% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $3.95 | +406.33% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.55 | +287.10% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $2.54 | -1.57% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.77 | +943.98% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.50 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $15.20 | -60.53% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.50 | +3,929.82% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $8.79 | +525.71% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $7.15 | +39.86% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $10.66 | +720.83% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.03 | +1,162.14% | 3 | Feb 9, 2021 |
Orchestra BioMed Holdings
Aug 13, 2025
Maintains: Buy
Price Target: $20
Current: $2.66
Upside: +651.88%
Korro Bio
Aug 13, 2025
Maintains: Buy
Price Target: $25
Current: $18.93
Upside: +32.07%
Coya Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $14
Current: $6.20
Upside: +125.81%
Arrowhead Pharmaceuticals
Aug 11, 2025
Maintains: Buy
Price Target: $60
Current: $19.99
Upside: +200.15%
Arbutus Biopharma
Aug 11, 2025
Maintains: Buy
Price Target: $5
Current: $3.37
Upside: +48.37%
ProQR Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $2.02
Upside: +98.51%
Avidity Biosciences
Aug 8, 2025
Maintains: Buy
Price Target: $75
Current: $46.15
Upside: +62.51%
SAB Biotherapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $20 → $12
Current: $2.16
Upside: +455.56%
Silence Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $35
Current: $5.82
Upside: +501.37%
Alnylam Pharmaceuticals
Aug 1, 2025
Maintains: Buy
Price Target: $325 → $400
Current: $432.52
Upside: -7.52%
Jul 29, 2025
Maintains: Buy
Price Target: $50 → $38
Current: $12.24
Upside: +210.46%
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $0.73
Upside: +585.87%
Jun 23, 2025
Initiates: Buy
Price Target: $60
Current: $32.91
Upside: +82.32%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $15.97
Upside: -62.43%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $3.95
Upside: +406.33%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.55
Upside: +287.10%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $2.54
Upside: -1.57%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.77
Upside: +943.98%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.50
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $15.20
Upside: -60.53%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.50
Upside: +3,929.82%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $8.79
Upside: +525.71%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $7.15
Upside: +39.86%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $10.66
Upside: +720.83%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.03
Upside: +1,162.14%